269 related articles for article (PubMed ID: 12118389)
21. Delineating neck targets for intensity- modulated radiation therapy of head and neck cancer. What we learned from marginal recurrences?
David MB; Eisbruch A
Front Radiat Ther Oncol; 2007; 40():193-207. PubMed ID: 17641510
[TBL] [Abstract][Full Text] [Related]
22. Influence of intravenous contrast agent on dose calculations of intensity modulated radiation therapy plans for head and neck cancer.
Choi Y; Kim JK; Lee HS; Hur WJ; Hong YS; Park S; Ahn K; Cho H
Radiother Oncol; 2006 Nov; 81(2):158-62. PubMed ID: 17050020
[TBL] [Abstract][Full Text] [Related]
23. Intensity-modulated radiation therapy in head and neck cancers: an update.
Lee N; Puri DR; Blanco AI; Chao KS
Head Neck; 2007 Apr; 29(4):387-400. PubMed ID: 16358297
[TBL] [Abstract][Full Text] [Related]
24. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420
[TBL] [Abstract][Full Text] [Related]
25. Value of FDG PET in assessment of treatment response and surveillance in head-and-neck cancer patients after intensity modulated radiation treatment: a preliminary report.
Yao M; Graham MM; Smith RB; Dornfeld KJ; Skwarchuk M; Hoffman HT; Funk GF; Graham SM; Menda Y; Buatti JM
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1410-8. PubMed ID: 15590172
[TBL] [Abstract][Full Text] [Related]
26. Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer.
Bussels B; Maes A; Hermans R; Nuyts S; Weltens C; Van den Bogaert W
Radiother Oncol; 2004 Aug; 72(2):119-27. PubMed ID: 15297131
[TBL] [Abstract][Full Text] [Related]
27. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
28. Evidence-based organ-sparing radiotherapy in head and neck cancer.
Dirix P; Nuyts S
Lancet Oncol; 2010 Jan; 11(1):85-91. PubMed ID: 20129131
[TBL] [Abstract][Full Text] [Related]
29. Intensity-modulated radiation therapy and xerostomia.
Chambers MS; Weber RS; Garden AS
J Calif Dent Assoc; 2006 Sep; 34(9):743-8. PubMed ID: 17022299
[TBL] [Abstract][Full Text] [Related]
30. Intensity modulated radiotherapy for high risk prostate cancer based on sentinel node SPECT imaging for target volume definition.
Ganswindt U; Paulsen F; Corvin S; Eichhorn K; Glocker S; Hundt I; Birkner M; Alber M; Anastasiadis A; Stenzl A; Bares R; Budach W; Bamberg M; Belka C
BMC Cancer; 2005 Jul; 5():91. PubMed ID: 16048656
[TBL] [Abstract][Full Text] [Related]
31. Future issues in highly conformal radiotherapy for head and neck cancer.
Feng M; Eisbruch A
J Clin Oncol; 2007 Mar; 25(8):1009-13. PubMed ID: 17350951
[TBL] [Abstract][Full Text] [Related]
32. Dosimetric comparison of helical tomotherapy and linac-IMRT treatment plans for head and neck cancer patients.
Zhang X; Penagaricano J; Moros EG; Corry PM; Yan Y; Ratanatharathorn V
Med Dosim; 2010; 35(4):264-8. PubMed ID: 19944587
[TBL] [Abstract][Full Text] [Related]
33. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
34. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer.
Parliament MB; Scrimger RA; Anderson SG; Kurien EC; Thompson HK; Field GC; Hanson J
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):663-73. PubMed ID: 14967418
[TBL] [Abstract][Full Text] [Related]
35. Patterns of failure after intensity-modulated radiotherapy in head and neck squamous cell carcinoma using compartmental clinical target volume delineation.
Bayman E; Prestwich RJ; Speight R; Aspin L; Garratt L; Wilson S; Dyker KE; Sen M
Clin Oncol (R Coll Radiol); 2014 Oct; 26(10):636-42. PubMed ID: 24928558
[TBL] [Abstract][Full Text] [Related]
36. Positron emission tomography/computed tomography for target delineation in head and neck cancers.
Ahn PH; Garg MK
Semin Nucl Med; 2008 Mar; 38(2):141-8. PubMed ID: 18243850
[TBL] [Abstract][Full Text] [Related]
37. Comparing 3DCRT and inversely optimized IMRT planning for head and neck cancer: equivalence between step-and-shoot and sliding window techniques.
Longobardi B; De Martin E; Fiorino C; Dell'oca I; Broggi S; Cattaneo GM; Calandrino R
Radiother Oncol; 2005 Nov; 77(2):148-56. PubMed ID: 16260056
[TBL] [Abstract][Full Text] [Related]
38. [18FDG] PET-CT-based intensity-modulated radiotherapy treatment planning of head and neck cancer.
El-Bassiouni M; Ciernik IF; Davis JB; El-Attar I; Reiner B; Burger C; Goerres GW; Studer GM
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):286-93. PubMed ID: 17707283
[TBL] [Abstract][Full Text] [Related]
39. Hypothyroidism after 3-dimensional conformal radiotherapy and intensity-modulated radiotherapy for head and neck cancers: prospective data from 2 randomized controlled trials.
Murthy V; Narang K; Ghosh-Laskar S; Gupta T; Budrukkar A; Agrawal JP
Head Neck; 2014 Nov; 36(11):1573-80. PubMed ID: 23996654
[TBL] [Abstract][Full Text] [Related]
40. A dynamic supraclavicular field-matching technique for head-and-neck cancer patients treated with IMRT.
Duan J; Shen S; Spencer SA; Ahmed RS; Popple RA; Ye SJ; Brezovich IA
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):959-72. PubMed ID: 15465215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]